🇺🇸 FDA
Patent

US 9278124

Hypoxia and hyaluronan and markers thereof for diagnosis and monitoring of diseases and conditions and related methods

granted A61KA61K31/396A61K31/407

Quick answer

US patent 9278124 (Hypoxia and hyaluronan and markers thereof for diagnosis and monitoring of diseases and conditions and related methods) held by HALOZYME, INC. expires Mon Mar 03 2036 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
HALOZYME, INC.
Grant date
Tue Mar 08 2016 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Mar 03 2036 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
51
CPC classes
A61K, A61K31/396, A61K31/407, A61K31/4709, A61K31/473